2020
DOI: 10.33472/afjbs.2.1.2020.1-8
|View full text |Cite
|
Sign up to set email alerts
|

Phenylketonuria: Genes in phenylketonuria, diagnosis, and treatments

Abstract: Introduction: Phenylketonuria (PKU) is a rare autosomal-recessive disorder inherited in accordance with the law of segregation. Detection tools for people with PKU can include Sanger Sequencing (SS) and Next Generation Sequencing (NGS). Diet therapy, Large Neutral Amino Acids (LNAA), and Specific Nutrient Combination (SNC) can help alleviate people with PKU. In the future, genetic manipulation techniques can help to eliminate PKU. Objectives: In this review, the author describes the progress in a study that fo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…Untreated individuals may experience severe intellectual disability, seizures, behavioral and psychiatric issues, motor problems, as well as characteristic physical features such as fair skin, light-colored eyes and hair, eczema, and a moldy odor [2]. Despite being the most common amino acid metabolism disorder, the underlying mechanisms of brain dysfunction in patients with PKU remain poorly understood, warranting further research to facilitate the development of pathophysiology-driven therapies [10,11].…”
Section: Introductionmentioning
confidence: 99%
“…Untreated individuals may experience severe intellectual disability, seizures, behavioral and psychiatric issues, motor problems, as well as characteristic physical features such as fair skin, light-colored eyes and hair, eczema, and a moldy odor [2]. Despite being the most common amino acid metabolism disorder, the underlying mechanisms of brain dysfunction in patients with PKU remain poorly understood, warranting further research to facilitate the development of pathophysiology-driven therapies [10,11].…”
Section: Introductionmentioning
confidence: 99%